| Stage | PKG | % of rev | MCHP | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $2.5B | 100.00% | $1.5B | 100.00% | PKG ×1.68 |
| Gross profit | $513M | 20.58% | $939M | 63.24% | MCHP +42.7pp |
| Operating income | $291M | 11.70% | $337M | 22.68% | MCHP +11.0pp |
| Pre-tax income | $259M | 10.40% | $290M | 19.53% | MCHP +9.1pp |
| Net income | $192M | 7.72% | $230M | 15.48% | MCHP +7.8pp |
| Stage | PKG | MCHP | Gap · A − B |
|---|---|---|---|
| Revenue | $2.5B100.00% | $1.5B100.00% | PKG ×1.68 |
| Gross profit | 20.58%$513M | 63.24%$939M | MCHP +42.7pp |
| Operating income | 11.70%$291M | 22.68%$337M | MCHP +11.0pp |
| Pre-tax income | 10.40%$259M | 19.53%$290M | MCHP +9.1pp |
| Net income |
| 7.72%$192M |
| 15.48%$230M |
| MCHP +7.8pp |
No shared counterparties.